通过基于图形图的时间线可视化来传达癌症治疗
Helena Klara Jambor1,2, Julian Ketges1,3, Anna Lea Otto3
1National Center for Tumor Diseases, University Cancer Center, NCT-UCC, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, 01307 Dresden, Germany.
Journal of the American Medical Informatics Association : JAMIA
|January 17, 2025
概括
视觉时间表显著改善了患者和医生对癌症治疗计划的理解和回忆. 这些视觉辅助工具增强了沟通和对癌症护理的信心.
科学领域:
- 在瘤学瘤学.
- 医学沟通 医学沟通
- 医疗信息学 医疗信息学
背景情况:
- 对癌症治疗途径的有效沟通对于患者的理解和坚持至关重要.
- 传统方法可能并不总是能清楚地传达复杂的治疗信息.
- 视觉辅助提供了一个有希望的途径,以提高患者的理解.
研究的目的:
- 评估癌症治疗沟通视觉时间表的可读性,理解性和临床可用性.
- 评估视觉辅助工具如何影响患者和参与者对治疗计划的理解.
- 为了比较视觉时间线与仅有音频信息的有效性.
主要方法:
- 进行了2次在线调查 (306名和160名参与者) 和1次面对面的临床评估 (30名患者,24名医生).
- 评估对仅使用音频与视觉辅助器件的治疗途径的理解.
- 评估对关键治疗术语的理解和患者对治疗途径的回忆.
主要成果:
- 视觉时间表,特别是图形图,显著改善了治疗术语的沟通 (透明度超过85%).
- 视觉时间表提高了正确的响应率,增加了信心,并获得了比仅音频方法更高的信息质量评级.
- 患者表现出治疗途径的良好理解 (0.82) 和回忆 (0.71),患者和医生都发现视觉辅助工具有帮助.
结论:
- 视觉时间表是有效的工具,可以提高患者对癌症治疗沟通的理解和信心.
- 将视觉辅助工具整合到患者咨询中得到了患者和医生的支持.
- 可访问的视觉辅助器对瘤学中不同患者群体具有潜在的好处.
更多相关视频
相关概念视频
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K


